We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+1.66%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$40.3B
AUM Growth
-$672M
(-1.6%)
Cap. Flow
-$694M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
14.49%
Holding
2,585
New
23
Increased
499
Reduced
843
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$297M |
| 2 |
Tapestry
TPR
|
+$225M |
| 3 |
SLB Ltd
SLB
|
+$167M |
| 4 |
Qualcomm
QCOM
|
+$165M |
| 5 |
Applied Materials
AMAT
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$197M |
| 2 |
Nike
NKE
|
+$187M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$185M |
| 4 |
Intel
INTC
|
+$177M |
| 5 |
Cognizant
CTSH
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.25% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 12.55% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Horace Mann Educators
HMN
$2.14B
| $14.9M | 0.04% |
470,931
+95,077
| +25% | +$2.92M |
|
427
Vanguard S&P 500 ETF
VOO
$1.03T
| $14.8M | 0.04% |
78,400
-41,498
| -35% | -$7.43M |
|
428
Boston Scientific
BSX
$73.1B
| $14.7M | 0.04% |
784,067
-17,044
| -2% | -$299K |
|
|
429
Cognizant
CTSH
$26.3B
| $14.7M | 0.04% |
235,228
-2,939,427
| -93% | -$171M |
|
430
Becton Dickinson
BDX
$48.9B
| $14.7M | 0.04% |
99,561
+15,015
| +18% | +$2.13M |
|
431
Weyerhaeuser
WY
$18.2B
| $14.7M | 0.04% |
474,921
+167,417
| +54% | +$4.47M |
|
|
AET
432
DELISTED
Aetna Inc
AET
| $14.7M | 0.04% |
130,897
-14,574
| -10% | -$1.56M |
|
433
Centene
CNC
$32.9B
| $14.7M | 0.04% |
476,576
+102,154
| +27% | +$3.05M |
|
434
Boston Properties
BXP
$10.8B
| $14.6M | 0.04% |
114,784
-5,010
| -4% | -$595K |
|
435
Carnival Corporation Ltd
CCL
$38B
| $14.6M | 0.04% |
275,803
+105,550
| +62% | +$5.11M |
|
436
Sempra
SRE
$55.1B
| $14.5M | 0.04% |
278,808
-955,570
| -77% | -$46M |
|
437
Steel Dynamics
STLD
$38.5B
| $14.5M | 0.04% |
642,658
+4,353
| +0.7% | +$82K |
|
|
PXD
438
DELISTED
Pioneer Natural Resource Co.
PXD
| $14.4M | 0.04% |
102,458
+6,930
| +7% | +$859K |
|
439
Pacira BioSciences
PCRX
$974M
| $14.4M | 0.04% |
272,165
-50,350
| -16% | -$2.95M |
|
440
Kroger
KR
$34.6B
| $14.4M | 0.04% |
376,836
-5,808
| -2% | -$224K |
|
441
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $14.3M | 0.04% |
351,776
+45,260
| +15% | +$1.72M |
|
|
LHO
442
DELISTED
LaSalle Hotel Properties
LHO
| $14.3M | 0.04% |
565,741
-13,950
| -2% | -$331K |
|
443
F5
FFIV
$23.2B
| $14.3M | 0.04% |
135,189
-55,999
| -29% | -$5.37M |
|
|
MRO
444
DELISTED
Marathon Oil Corporation
MRO
| $14.2M | 0.04% |
1,279,088
+27,737
| +2% | +$259K |
|
445
Portland General Electric
POR
$5.66B
| $14.2M | 0.04% |
359,667
-41,850
| -10% | -$1.6M |
|
446
Paychex
PAYX
$43.1B
| $14.1M | 0.04% |
261,335
+37,496
| +17% | +$1.89M |
|
447
Gorman-Rupp
GRC
$2.16B
| $14M | 0.03% |
540,284
+14,500
| +3% | +$361K |
|
448
NetApp
NTAP
$39B
| $13.9M | 0.03% |
510,667
+57,358
| +13% | +$1.39M |
|
449
McKesson
MCK
$103B
| $13.9M | 0.03% |
88,571
-757,798
| -90% | -$122M |
|
450
Zimmer Biomet
ZBH
$18.7B
| $13.9M | 0.03% |
134,137
+3,237
| +2% | +$313K |
|
Similar funds
VOYA Investment Management's Q1 2016 Portfolio in Review
As of Q1 2016, VOYA Investment Management held 2,585 positions worth $40.3B, down 1.6% from $41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 3.7%. VOYA Investment Management opened 23 new positions and exited 72, leaving the 2,585-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- VOYA Investment Management's largest Q1 2016 buy was AstraZeneca: 495,025 shares worth $27.9M.
- VOYA Investment Management added most to AbbVie in Q1 2016, an estimated $297M increase.
- VOYA Investment Management's biggest Q1 2016 reduction was Pfizer, cutting an estimated $197M.
- VOYA Investment Management fully exited Blackstone in Q1 2016, selling an estimated $61.8M.
- VOYA Investment Management's ten largest holdings make up 14% of its $40.3B portfolio in Q1 2016.
- VOYA Investment Management opened 23 new positions and closed 72 in Q1 2016.
- VOYA Investment Management's portfolio value fell 1.6% quarter-over-quarter to $40.3B.
Based on VOYA Investment Management's 13F filing for Q1 2016, filed 16 May 2016.